|Delivery||Report Code||Available Format|
|24-72 Working Hours||LS10290|
The global next-generation sequencing market is growing significantly due to advances in next-generation technologies, increasing scientists and researchers’ compliance for next-generation sequencing, and low cost of next-generation sequencing methods compared to conventional sequencing methods in the industry. The unexplored next-generation sequencing market in emerging economies and increasing focus for the development of personalized medicine are creating opportunities for the global next-generation sequencing market to grow at a considerable rate in the coming years. The advanced research and development activities by the major players are propelling the demand for cost effective and efficient next-generation sequencing platforms. However, interpretation of large volume of complex sequencing data through next-generation sequencing platforms is a major challenge in global next-generation sequencing market.
Usage of nanopore sequencing technology for the development of next-generation sequencing platforms is a trend in global next-generation sequencing market. Next-generation sequencing provides high throughput sequencing to researchers and scientists with high specificity and speed, and reduced cost. Conventional sequencing methods, such as Sanger method that are slower, expensive and require large amount of template DNA next-generation sequencing, has overcome these limitations with more accurate results.
The global next-generation sequencing market is categorized as technology type, sequencing workflow, applications, and end-users. Based on technology type, the next-generation sequencing market is categorized as pyrosequencing, ion-semiconductor sequencing, sequencing by synthesis, single molecule realtime sequencing, and sequencing by ligation. The sequencing by synthesis segment leads the global next-generation sequencing market. Based on sequencing workflow, the next-generation sequencing market is categorized as next-generation pre-sequencing, next-generation sequencing platforms, and next-generation sequencing services.
Based on applications, the next-generation sequencing market can be categorized as diagnostics, drug discovery, animal and agriculture research, personalized medicine, and others. End-users of next-generation sequencing include academic and research institutes, biopharmaceutical and biotechnology companies, hospitals, and others. Academic and research institutes lead the global next-generation sequencing market.
Some of the factors driving the growth of the global next-generation sequencing market are advances in sequencing technology, increasing adherence of researchers and scientists for next-generation sequencing, increasing demand for quicker, cheaper and accurate sequencing methods, and increasing research and development activities in genomics and proteomics. In addition, the National Human Genome Research Institute’s goal to reduce human genome sequencing cost upto 100 times is propelling pharmaceutical and biotechnology companies to invest large capital for the development of next-generation sequencing; this in turn is expected to drive the global next-generation sequencing market. However, complexity of data interpretation and lack of service providers are some of the factors restraining the growth of the global next-generation sequencing market to some extent.
Geographically, North America will be leading the global next-generation sequencing market in the coming years due to high healthcare expenditure, technological advancements, presence of large number of academic and research institutes, and high scientists’ compliance for next-generation sequencing devices. Asia-Pacific is the fastest growing region in the global next-generation sequencing market. The major reasons for the fastest growth in the region are increasing healthcare expenditure, increasing genomics and proteomics related research activities and improving healthcare infrastructure. Moreover, the next-generation sequencing market is growing rapidly due to the government funding for research activities, and increasing number of academic and research institutes in emerging economies, such as India and China, of Asia-Pacific region.
Some of the major players operating in the global next-generation sequencing market are Agilent Technologies, Inc., F. Hoffmann-La Roche AG, Biomatters, Ltd., GATC Biotech AG, Illumina, Inc., Thermo Fisher Scientific, Inc., Pacific Biosciences, Oxford Nanopore Technologies, Ltd, Macrogen, Inc. among others.